1. Studies in rodents with the dipeptidyl peptidase‐4 inhibitor vildagliptin to evaluate possible drug‐induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man. Issue 1 (9th September 2012) Authors: Busch, S. J.; Hoffmann, P.; Sahota, P.; Johnson, R.; Kothny, W.; Meyer, F.; Foley, J. E. Journal: Diabetes, obesity & metabolism Issue: Volume 15:Issue 1(2013:Jan.) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗